June 17, 2019
Drug Makers Challenge New Rule Requiring Drug Prices in TV Ads
Lawsuit against the rule filed Friday by Merck, Eli Lilly, and Amgen
MONDAY, June 17, 2019 (HealthDay News) -- Three large drug makers have launched a legal challenge against the Trump administration's rule requiring the prices of drugs to be included in television ads.
A lawsuit against the rule, set to take effect July 9, was filed Friday in federal court in Washington, D.C., by Merck, Eli Lilly, and Amgen, The New York Times reported. A trade group for advertisers is also part of the lawsuit.
The lawsuit contends that the rule is illegal because it violates the companies' First Amendment rights and claims that the pricing information could mislead consumers because insurers often cover most of a drug's cost, The Times reported.
The rule applies to any drug with a list price of more than $35 a month.
Physician's Briefing
Products
Language
English
News types
Institutional
Topics
Health Costs
Media
Prescription Drugs
Specialties
Allergy
Cardiology
Dermatology
Diabetes & Endocrinology
Family Practice
Gastroenterology
HIV & AIDS
Infectious Disease
Neurology
OBGYN & Women's Health
Hematology & Oncology
Ophthalmology
Orthopedics
Pediatrics
Psychiatry
Pulmonology
Rheumatology
Surgery
Urology
Internal Medicine
Otolaryngology
